Spruce Biosciences Raises $88 Million in Series B Financing, co-led …

San Francisco, California — February 19, 2020 – Spruce Biosciences today announced it has raised $88 million in Series B financing co-led by Omega Funds and Abingworth and …


Install CouponFollow Chrome Extension   CouponFollow Extension

$88
OFF

Spruce Biosciences Raises $88 Million In Series B Financing, Co-led …

6 days from now

San Francisco, California — February 19, 2020 – Spruce Biosciences today announced it has raised $88 million in Series B financing co-led by Omega Funds and Abingworth and …

sprucebio.com

$88
OFF

Wilson Sonsini Advises Spruce Biosciences On IP Matters Related …

6 days from now

On February 19, 2020, Spruce Biosciences, a clinical stage biopharmaceutical company developing therapeutics for rare endocrine diseases, announced it has raised $88 million in …

wsgr.com

$88
OFF

Omega Funds Co-leads Spruce Biosciences' $88M Series B

6 days from now

Feb 19, 2020  · Gunderson Dettmer client Omega Funds co-led the $88 million Series B financing of Spruce Biosciences, a bio-pharmaceutical company developing novel therapies for rare …

gunder.com

$88
OFF

Spruce Biosciences Raises $88 Million In Series B Financing, Co-led …

6 days from now

Feb 20, 2020  · Proceeds to advance development of Tildacerfont in Congenital Adrenal Hyperplasia and other indications

biospace.com

$53
OFF

Spruce Biosciences – Funding, Valuation, Investors, News

6 days from now

Spruce Biosciences Announces $53.6 Million Private Placement Financing: ... Spruce Biosciences Raises $88M in Series B Financing: Spruce Biosciences, a San Francisco, CA-based clinical …

parsers.vc

$88
OFF

Spruce Biosciences Closes On $88 Million Series B Round

6 days from now

Feb 20, 2020  · Spruce intends to use the funds raised to evaluate tildacerfont to reduce glucocorticoid steroid usage in adults with CAH, and to complete proof-of-concept trials in …

biospace.com

$88
OFF

Spruce Biosciences Raises $88M In Series B Financing, Co-led By …

6 days from now

SAN FRANCISCO, February 20, 2020-- Spruce Biosciences today announced it has raised $88 million in Series B financing co-led by Omega Funds and Abingworth and supported by …

thetrustedinsight.com

$88
OFF

Spruce Biosciences : Raises $88 Million In Series B Financing, Co …

6 days from now

Feb 20, 2020  · - Proceeds to advance development of Tildacerfont in Congenital Adrenal Hyperplasia and other indications - Existing Investors Novo Holdings and RiverVest Venture …

marketscreener.com

$88
OFF

Series B - Spruce Biosciences - 2020-02-20 - Crunchbase

6 days from now

Feb 20, 2020  · Spruce Biosciences — Spruce Biosciences Raises $88 Million in Series B Financing, co-led by Omega Funds and Abingworth - Spruce Biosciences News • Feb 20, …

crunchbase.com

$88
OFF

Spruce Biosciences Raises $88 Million To Advance Rare Endocrine …

6 days from now

Feb 20, 2020  · Spruce Biosciences Raises $88 Million to Advance Rare Endocrine Disease Pipeline. February 20, 2020. Rare Daily Staff. Spruce Biosciences completed an $88 million …

globalgenes.org

$88
OFF

Spruce Biosciences Raises $88 Million In Series B Financing, Co-led …

6 days from now

Feb 20, 2020  · SAN FRANCISCO--(BUSINESS WIRE)--Spruce Biosciences today announced it has raised $88 million in Series B financing co-led by Omega Funds and Abingworth and …

businesswire.com

$80
OFF

Sherlock Biosciences Raises $80 Million In Series B Financing To ...

6 days from now

Mar 8, 2022  · Funding led by Novalis LifeSciences to develop novel diagnostic products, powered by Sherlock’s proprietary platform leveraging CRISPR and synthetic biology BOSTON – …

sherlock.bio

$116
OFF

Sudo Biosciences Raises $116 Million In Series B Financing

6 days from now

Dec 20, 2023  · Carmel, USA-based biotech Sudo Biosciences today announced the closing of a $116 million Series B financing. The Frazier-founded is company committed to designing and …

thepharmaletter.com

$88
OFF

Spruce Biosciences Raises $88 Million In Series B Financing, Co …

6 days from now

Spruce Biosciences Raises $88 Million in Series B Financing, co-led by Omega Funds and ... California February 19, 2020 Spruce Biosciences today announced it has raised $88 million in …

sprucebio.com

$85
OFF

Kyverna Therapeutics Closes $85 Million Series B Financing Led By ...

6 days from now

EMERYVILLE, Calif., Jan. 26, 2022 /PRNewswire/ -- Kyverna Therapeutics ("Kyverna"), a cell therapy company engineering a new class of therapies for serious autoimmune diseases, …

synbiobeta.com

$60
OFF

GRO Biosciences Closes $60M Series B Financing Co-Led By Atlas …

6 days from now

BOSTON, July 19, 2024 – GRO Biosciences Inc. (“GRObio”), a biotechnology company leveraging synthetic biology to expand the amino acid alphabet and deliver on the promise of …

grobio.com

$88
OFF

Spruce Biosciences Raises $88 Million In Series B Financing, Co-led …

6 days from now

San Francisco, California — February 19, 2020 – Spruce Biosciences today announced it has raised $88 million in Series B financing co-led by Omega Funds and Abingworth and …

healthcap.eu

FAQs about Spruce Biosciences Raises $88 Million in Series B Financing, co-led … Coupon?

Who owns spruce Biosciences stock?

Spruce Biosciences' stock is owned by many different institutional and retail investors. Top institutional investors include Rosalind Advisors Inc. (3.67%) and Acadian Asset Management LLC (0.90%). Insiders that own company stock include Camilla V Simpson and Holdings A/S Novo. View institutional ownership trends. ...

Who is spruce Biosciences?

Spruce Biosciences is a late-stage biopharmaceutical company dedicated to developing novel therapies for rare endocrine disorders with significant unmet medical needs. ...

Why were spruce Biosciences shares plunging 77 percent in pre-market trading?

(RTTNews) - Shares of Spruce Biosciences Inc. (SPRB) were plunging more than 77 percent in pre-market trading on Nasdaq after the late-stage biopharmaceutical company reported a wider net loss in fiscal 2023, and said its CAHmelia-203 study failed to meet targets. ...

Why did spruce Biosciences (SPRB) stock drop on Thursday?

Spruce Biosciences Inc (NASDAQ:SPRB) shares plummeted on Thursday after the company released topline results from its CAHmelia-203 Phase 2b study of tildacerfont in adult classic congenital adrenal hyperplasia (CAH) and its CAHptain-205 study of tildacerfont in pediatric classic CAH. ...

How much cash does spruce biosciences have?

The company currently has over $81 million in cash and cash equivalents. In pre-market activity on Nasdaq, Spruce Biosciences shares were trading at $1.17, down 77.5 percent. (RTTNews) - Shares of Spruce Biosciences Inc. (SPRB) were plunging more than 77 percent in pre-market trading on Nasdaq after the late-stage bioph... ...

How many times has spruce Biosciences surpassed consensus EPS estimates?

Over the last four quarters, the company has surpassed consensus EPS estimates four times. Spruce Biosciences, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $1.61 million for the quarter ended June 2024, surpassing the Zacks Consensus Estimate by 3.87%. This compares to year-ago revenues of $2.17 million. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension